Citadel Advisors’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Hold |
0
| – | – | – | 5967 |
|
2025
Q1 | – | Hold |
0
| – | – | – | 6063 |
|
2024
Q4 | – | Sell |
-64,226
| Closed | -$118K | – | 6080 |
|
2024
Q3 | $118K | Sell |
64,226
-203,546
| -76% | -$375K | ﹤0.01% | 4855 |
|
2024
Q2 | $268K | Buy |
267,772
+123,587
| +86% | +$124K | ﹤0.01% | 4403 |
|
2024
Q1 | $285K | Sell |
144,185
-21,952
| -13% | -$43.5K | ﹤0.01% | 4446 |
|
2023
Q4 | $259K | Buy |
+166,137
| New | +$259K | ﹤0.01% | 4369 |
|
2023
Q2 | – | Sell |
-44,460
| Closed | -$145K | – | 5882 |
|
2023
Q1 | $145K | Sell |
44,460
-17,816
| -29% | -$58.3K | ﹤0.01% | 4755 |
|
2022
Q4 | $313K | Buy |
+62,276
| New | +$313K | ﹤0.01% | 4289 |
|
2022
Q1 | – | Sell |
-33,573
| Closed | -$106K | – | 6433 |
|
2021
Q4 | $106K | Buy |
+33,573
| New | +$106K | ﹤0.01% | 5869 |
|